By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is overwhelmingly bearish on SpaceX's current valuation and AI revenue, citing extreme P/S ratios, massive capex headwinds, regulatory risks, and governance concerns. They advise extreme caution and warn of potential dilution and price weakness.
Risk: Regulatory risks, customer concentration in AI revenue, and Elon Musk's voting control are the primary concerns, which could evaporate the perceived 'AI revenue' and lead to downside for investors.
Opportunity: No significant opportunities were highlighted in the discussion.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Shares of Space Exploration Technologies (NASDAQ: SPCX), better known as SpaceX, have experienced a volatile journey since debuting as the biggest IPO in Wall Street history. When initial excitement faded for the company's June 12 public debut, the stock fell into a tailspin.
The share price changed course after Elon Musk's company reported second-quarter earnings on Aug. 4. By Aug. 12, SpaceX stock was up nearly 40% from the low of $104.83 reached the day before earnings. As of Aug. 17, it's back above the official IPO pricing of $135.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
The recovery is a promising sign, but does it mean now is the time to buy? To answer that question, here's a deeper dive into the company Musk controls with over 80% of the voting power.
SpaceX stock fell post-IPO due to various factors, including expiration of an initial lockup period for insiders and early investors, which made more shares available for trading than the roughly 639 million sold in the IPO. Another was the company's enormous capital expenditures. Its 2025 capex was $20.7 billion, nearly double the 2024 total.
However, many positives in SpaceX's Q2 earnings report propelled the stock upward. Revenue rose a whopping 92% year over year to $7.8 billion. Its net loss shrank to $541 million, down substantially from $1 billion in the prior year.
Although the company is known for its space-based offerings, Q2 revenue from its artificial intelligence business soared to $2.6 billion, up from $737 million in 2025. This spectacular sales growth suggests SpaceX's massive capital investments in AI infrastructure could end up paying off.
One of these investments is its Terafab project, a joint venture with Elon Musk's other company, Tesla, to create a massive semiconductor manufacturing facility. Terafab will produce AI chips for both businesses. Musk called the initiative "the most epic chip-building exercise in history."
SpaceX's AI pursuit is important for investors to understand because management believes artificial intelligence is a far bigger opportunity than its rocket business. The company estimates AI's total addressable market (TAM) at an astounding $26.5 trillion compared to $370 billion for its space launch operations.
Consequently, investing in shares means buying into Musk's vision that artificial intelligence is central to SpaceX's future and a belief in the company's ability to capture a meaningful share of the colossal TAM at stake. It seems many investors are convinced.
That said, SpaceX stock is expensive, as demonstrated by a price-to-sales ratio exceeding 90. For comparison, consider that shares of AI semiconductor chip leader Nvidia sport a more reasonable sales multiple of about 22.
With only one quarter of reported earnings as a public company, it's not known whether SpaceX's Q2 performance signals the start of a sustainable trend. Moreover, additional shares are scheduled to unlock in the coming months, including about 700 million in both September and October. This flood of supply could push the share price down.
Given these considerations, the prudent approach is to wait for SpaceX stock to drop before deciding to buy.
Before you buy stock in Space Exploration Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Space Exploration Technologies wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $409,970! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,381,040!
Now, it’s worth noting Stock Advisor’s total average return is 969% — a market-crushing outperformance compared to 215% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of August 18, 2026. *
Robert Izquierdo has positions in Nvidia and Tesla. The Motley Fool has positions in and recommends Nvidia and Tesla. The Motley Fool has a disclosure policy.
Four leading AI models discuss this article
"SpaceX is a private company, and any claims regarding a public IPO or 'SPCX' ticker are factually incorrect and potentially fraudulent."
The premise that SpaceX (SPCX) is a viable public equity is fundamentally flawed because the company is private. This article discusses a 'historic IPO' and ticker 'SPCX' that do not exist; SpaceX remains a private entity, and no such ticker trades on the NASDAQ. Investors should be extremely wary of the 'AI pivot' narrative presented here, as it mirrors common 'pump' tactics. Even if we entertain the financials, a 90x price-to-sales ratio for a company burning $541 million quarterly is speculative madness. The reported $2.6 billion in AI revenue is likely an accounting classification shift rather than a sustainable business model, given the lack of independent verification.
If one assumes the article is describing a hypothetical scenario or a future IPO, the massive capital expenditure into the Terafab project could theoretically create a vertically integrated AI infrastructure moat that justifies a premium valuation.
"A 40% bounce off earnings does not validate a 90x P/S multiple when the company has one quarter of public financials, faces $1.4B in near-term share dilution, and depends entirely on Musk's ability to execute an unproven $26.5T TAM thesis."
This article conflates a post-earnings bounce with fundamental value, which is dangerous. Yes, SpaceX beat on revenue (+92% YoY) and reduced losses, but the P/S ratio of 90x versus Nvidia's 22x is not 'expensive'—it's potentially indefensible for a company with one quarter of public data and massive capex headwinds. The AI revenue jump ($737M to $2.6B) is striking, but the article doesn't clarify: is this recurring? Margin-accretive? The $700M+ share unlocks in Sept/Oct are real overhang. Most critically: Musk controls 80%+ voting power, creating acute governance risk and potential minority shareholder dilution.
If SpaceX's AI TAM thesis is even 10% correct and Q2 margins expand as capex normalizes post-2025, the stock could compound 3-5x over five years—making today's valuation a bargain relative to optionality, not a trap.
"SpaceX is priced for hypergrowth in AI without proven profitability; dilution and mega-capex risk could derail returns."
SpaceX's stock rebound appears narrative-driven rather than a genuine value signal. Q2 showed AI revenue accelerate to $2.6B on $7.8B revenue, but the company still posts a big overall loss and a massive 2025 capex run-rate of $20.7B. Valuation is extreme: P/S north of 90x and a huge hurdle to justify. Also, ~700M shares unlock in Sep/Oct risks near-term dilution and price weakness. The Terafab chip JV with Tesla hinges on speculative AI demand and execution. The article's optimism omits regulatory, supply-chain, and profitability risks that could derail the upside.
The counterargument is that AI demand could accelerate, Terafab could unlock meaningful margins, and the resulting profitability trajectory might justify the multiple despite dilution.
"N/A"
[Unavailable]
"SpaceX's valuation ignores the acute risk of regulatory intervention regarding spectrum and orbital rights that could invalidate its entire AI-revenue narrative."
Gemini and Claude are fixated on the P/S ratio, but they are ignoring the existential risk of Starlink's regulatory dependencies. SpaceX isn't just an AI play; it is a geopolitical utility. If the FCC or international regulators pivot on spectrum licensing, that $2.6B 'AI revenue' evaporates overnight. The valuation isn't just speculative; it is priced for a monopoly that hasn't secured its regulatory moat. We are ignoring the sovereign risk embedded in their orbital dominance.
"Regulatory risk to Starlink is structural but slow-moving; customer concentration in AI revenue is the immediate cliff risk nobody quantified."
Gemini's regulatory risk is real but overstated. Starlink's $2.6B AI revenue isn't orbital-dependent—it's ground infrastructure (data centers, compute). The FCC can't revoke spectrum overnight without Congressional action. However, nobody's flagged the actual vulnerability: AI revenue concentration. If two or three customers (likely hyperscalers) represent 60%+ of that $2.6B, customer concentration risk dwarfs regulatory risk. That's the real moat question.
"Governance risk (Musk's ~80% voting power) plus AI-revenue concentration magnifies downside, making SpaceX's lofty multiple fragile if regulators act or major customers renegotiate terms."
Gemini raised regulatory moats as the key; I’d add governance risk as the force multiplier. Musk’s 80%+ voting control means minority holders have almost no sway if regulators blink or a major customer pushes for better terms. That, plus AI revenue concentration across 2-3 hyperscalers, makes the valuation's 'moat' assumption fragile. If either side weakens, downside could overwhelm the quoted upside.
[Unavailable]
The panel consensus is overwhelmingly bearish on SpaceX's current valuation and AI revenue, citing extreme P/S ratios, massive capex headwinds, regulatory risks, and governance concerns. They advise extreme caution and warn of potential dilution and price weakness.
No significant opportunities were highlighted in the discussion.
Regulatory risks, customer concentration in AI revenue, and Elon Musk's voting control are the primary concerns, which could evaporate the perceived 'AI revenue' and lead to downside for investors.